Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain

Synapse

Volumn 3, Issue 1, 1989, Pages 96-97

  Seeman, Philip ^a   Guan, H C ^a   Niznik, Hyman B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE; RADIOISOTOPE;

AUTOPSY; BRAIN HOMOGENATE; CORPUS STRIATUM; HUMAN; HUMAN CELL; PRELIMINARY COMMUNICATION; RECEPTOR BINDING; SCHIZOPHRENIA;

ANIMAL; CORPUS STRIATUM; DOPAMINE; HUMAN; RACLOPRIDE; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SPIPERONE; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0024595594     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.890030113     Document Type: Article

References (5)

1. 2 receptor increase in PET study of schizophrenia
2. 3H‐raclopride
3. In vivo receptor binding: Attempts to improve specific/non‐specific ratios
4. 2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases
5. 2 dopamine receptors in drug‐naive schizophrenics